Session 1 – Mass Cytometry vs COVID-19
During the last months, the outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a great challenge to the human health, worldwide, with million of infections. We were immediately involved in studying the role of immune system in fighting SARS-CoV2, and have focused our attention on T lymphocytes, B cells and monocytes to investigate the mechanisms underlying the progressive leukopenia observed in patients.